GlassScriptPhysician profile
John A Huebner
NPI 1023118411
$4,573.67
in general payments reported to CMS, 2019-2025
19 companies · $590 in 2025
The $590 reported for 2025 was more than what 83% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,035 · 2022: $1,570 · 2023: $1,223 · 2024: $155 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Education: $45.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.18 |
| Education | $45.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $795.10 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $683.55 | 2021-2025 | |
| Boston Scientific Corporation | $551.77 | 2022-2025 | Emblem Mri S-Icd, Watchman Access System, Farapulse |
| Amgen INC. | $491.83 | 2021-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $387.83 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $371.96 | 2021-2023 | Brilinta |
| Janssen Pharmaceuticals, INC | $275.54 | 2021-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $194.78 | 2021-2023 | |
| Abbott Laboratories | $183.02 | 2022 | |
| Alnylam Pharmaceuticals INC. | $158.31 | 2022-2023 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $122.57 | 2022-2025 | Verquvo |
| Pfizer INC. | $108.85 | 2022-2023 | |
| Heartflow, INC. | $78.20 | 2022-2025 | Ffrct |
| Abiomed | $40.21 | 2022-2025 | |
| Biotronik INC. | $36.90 | 2023-2024 | Amvia Edge, Acticor 7 Vr-T Dx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $36.60 | 2022-2025 | Eliquis |
| Amarin Pharma, INC. | $20.03 | 2021 | |
| Irhythm Technologies, INC. | $18.33 | 2023 | Zio Xt Patch |
| Edwards Lifesciences Corporation | $18.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Huebner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.